|
Wednesday 4th June 2025 |
Text too small? |
Rua Bioscience advises that it has reached a settlement with Cann Group Limited (ASX:CAN), following legal proceedings initiated by Rua in February 2024.
As part of the legal proceedings, both parties undertook mediation which had led to this settlement. Rua Bioscience and Cann Group have executed new supply agreements to support their respective operations in the New Zealand and Australian medicinal cannabis markets. The commercial terms of the settlement are confidential and take effect immediately.
ENDS
No comments yet
TRA - Turners has record uptake of employee share program
RTO - Board change
Devon Funds Morning Note - 14 September 2026
TEM - Transaction in Own Shares
SCL - Scales increases ownership of Esro Petfood
September 14th Morning Report
BPG - Amended FY26 Annual Report and Presentation
WIN - Winton - Chris Meehan resigns as Directo
TEM - Transaction in Own Shares
WCO - Share Purchase Plan